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Abstract
In this study we aimed at retrospectively assessing in a homogeneous group of IVF patients whether the addition
of Early Embryo Viability Assessment (Eeva™) to standard morphology increases the accuracy of embryo selection in
case of double embryo transfer (DET) on day 3 or single embryo transfer (SET) on day 5. Eeva™ is an algorhythm
aimed at indicating on day 3, according to morphokinetic parameters observed in the first three days of embryo
growth, which embryos are more likely to develop into viable blastocysts and implant. A total number of 328
patients were included in the study; IVF or ICSI were performed and 428 embryos were transferred, either with DET
on day 5, or (when at least four top scored embryos were available on day 3) with SET of day 5. Four groups were
considered: (a) patients receiving day 3 DET with embryos selected by standard morphology (DET-3 M, n = 106,
receiving 212 embryos), (b) patients receiving day 3 DET with embryos selected by morphology plus Eeva™ (DET-3
ME group, n = 48, receiving 96 embryos), (c) patients receiving day 5 SET with a blastocyst selected by standard
morphology (SET-5 M group, n = 126, receiving 126 embryos), and (d) patients receiving day 5 SET with a blastocyst
selected by morphology plus Eeva™ (SET-5 ME group, n = 48, receiving 48 embryos). Overall, a clinical pregnancy
rate of 49.1%, implantation rate of 40%, and ongoing pregnancy rate of 43.6% were observed. The implantation
rate was significantly higher in DET-3 ME group than in DET-3 M group (44.8% vs. 30.2%, p < 0.02), whereas it was
comparable in groups DET-3 ME, SET-5 M and SET-5 ME. Differently, the ultrasound-verified clinical pregnancy rate
and the ongoing pregnancy rate at 12 weeks did not significantly differ in all four groups. Overall, our findings
suggest that Eeva™ algorhythm can improve embryo selection accuracy of standard morphology when ET on day 3
is scheduled, leading to a higher implantation rate, but its impact on ongoing pregnancy and live birth needs to be
further clarified.
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Introduction
Selecting the best embryo(s) to be transferred in uteri in
the same cycle or cryopreserved for a delayed transfer is
a key issue in human IVF. In the last decades, embryo
morphology was widely used for detecting embryo com-
petence, and several morphological scores applying to
cleavage stage (day 2 or 3) embryos were proposed, none
of them, however, being adopted as a worldwide-ac-
cepted standard. The strategy of transferring a single
embryo to avoid twin pregnancy was progressively
adopted in the last years, and extended culture to the
blastocyst stage, although rather complicated and time-
consuming, became quite popular, raising the need for
blastocyst morphological scores; also in this case, how-
ever, a thoroughly reliable method to select the best
blastocyst was not yet found.
Time-lapse embryo culture technology (TLT) is a ra-
ther recent approach to embryo selection. It allows the
continuous, dynamic assessment of embryo morpho-
logical changes without the need to remove embryos
from the incubator, thus limiting potentially detrimental
effects of changes in culture conditions [8]. To date,
however, only some studies reported higher clinical and
ongoing pregnancy rates using embryo selection by TLT
vs. the classical morphological embryo selection [12],
whereas other prospective randomized trials did not find
any improvement in IVF outcome with TLT [5, 9, 10].
To date, a convincing, final demonstration that TLT can
improve IVF results in terms of live births is still lacking.
Early Embryo Viability Assessment (Eeva™) is an algor-
hythm that applyes to a specific type of TLT system; it
was designed to predict blastocyst formation on the
basis of morphokinetic parameters observed in the first
three days of embryo growth. Eeva™ was aimed at indi-
cating on day 3 which embryos are more likely to de-
velop into viable blastocysts, and gives the potential
advantage to select the most competent embryos on day
3 without the need to extend culture till day 5, thus sav-
ing time and resources. Until now, however, only a few
studies assessing the impact of Eeva™ on cleaving em-
bryo selection were performed: a multicenter study con-
cluded that the combination of standard morphology
plus Eeva™ was more effective than standard morphology
alone in identifying embryos able to reach the blastocyst
stage [2]; other studies reported that Eeva™ application
improved the possibility to select embryos and increased
implantation and pregnancy rates [1, 16]. On the other
side, however, some authors reported no significant dif-
ferences in pregnancy rates when Eeva™ was used in as-
sociation with standard morphology vs. morphology
alone on day 3 [9] or vs. morphological selection alone
on day 5 [7, 18].
In the present study we aimed at retrospectively asses-
sing in a very homogeneously selected group of IVF
patients whether the addition of Eeva™ to standard
morphology increased the accuracy of embryo selection
in case of double embryo transfer (DET) on day 3 or sin-
gle embryo transfer (SET) on day 5.
Materials and methods
Patients
The study was designed as a retrospective analysis of
IVF cycles performed at our IVF Unit between March
2016 and July 2018. In order to minimize the risk of
interference by patient-related characteristics, we in-
cluded in the study a very homogenous group of care-
fully selected patients chosen with the following, strict
criteria: (a) age 28–40 years; (b) body mass index (BMI)
18–25); (c) ovarian reserve markers predicting a normal
response to gonadotropins (serum day 3 FSH < 12 IU/l,
AMH 1.2–5 ng/ml, antral follicle count (AFC) 8–15); (d)
verified normal response to controlled ovarian stimula-
tion (COS) performed by gonadotropin-releasing hor-
mone (GnRH)-agonist ″long″ protocol plus
recombinant FSH, with at least 6 retrieved oocytes; (e)
easy transfer of two embryos on day 3 (DET) or (in case
of at least 4 good-scoring embryos on day 3) of a single
blastocyst on day 5 (SET).
The study was carried out in accordance to the Declar-
ation of Helsinki and was authorized as an observational
study by the local Ethical Committee. A signed, written
consent was retrospectively obtained from all patients
accepting their data being included in the analysis.
Controlled ovarian stimulation (COS) and oocyte retrieval
All included patients underwent COS using the gonado-
tropin-releasing hormone (GnRH)-agonist ″long″
protocol with recombinant FSH (Gonal-F®, Merck,
Darmstadt, Germany) at individually tailored starting
daily dose (125–250 IU/day, subcutaneously). Follicular
growth was monitored by transvaginal US examination
plus serial measurements of circulating estradiol (E2),
performed every second day from stimulation day 7, and
adjusting FSH dose accordingly. When at least two folli-
cles reached 18mm mean diameter, with appropriate E2
levels, a single subcutaneous injection of 10,000 IU hCG
(Gonasi HP, IBSA, Pambio Noranco, Switzerland) was
administered to trigger ovulation. US-guided oocyte re-
trieval (OPU) was performed 35–37 h later under local
anesthesia (paracervical block). The aspirated follicular
fluid was immediately observed under stereomicroscope
to retrieve the corresponding oocyte, that was then
washed in buffered medium and incubated in controlled
atmosphere until fertilization procedure.
Preparation of semen samples and in vitro fertilization
Semen samples were examined to assess sperm concen-
tration, motility, and morphology according to the
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World Health Organization guidelines, and were then
prepared by density gradient centrifugation in order to
select normally motile, morphologically normal sperm-
atozoa. Conventional IVF or ICSI injection was per-
formed on all available oocytes within 4 h after OPU,
and the occurrence of normal fertilization was assessed
after 16–18 h of incubation in controlled atmosphere by
evaluating the presence of two pronuclei (2PN) and the
extrusion of the second polar body.
Embryo selection and transfer
Fertilized oocytes were placed in pools in a 4-wells dish
(Thermo Scientific, Denmark), and were cultured in
pre-equilibrated Cleavage medium (Cook) overlain
with mineral oil, using the same tri-gas box incuba-
tors (Panasonic) containing an atmosphere of 5% O2
and 6–7% CO2, balanced with N2. A medium refresh
step on day 3 was performed.
When only the classical morphological evaluation was
applied, the Integrated Morphology Cleavage Score
(IMCS) was used. IMCS is the only score constructed to
be evidence-based, as it was obtained comparing im-
planted embryos vs. non-implanted embryos in a rather
large number of IVF cycles ending in double embryo
transfer (DET) [6]. Due to its peculiar characteristics,
IMCS has been incorporated in a complex prediction
model for IVF outcome, proven to predict live birth with
a remarkably good accuracy [14]. After IMCS-based
morphological selection, either a double embryo transfer
(DET) on day 3 or a single blastocyst transfer (SET) on
day 5 were performed. SET was chosen when at least 4
good scoring (> 8/10 at IMCS) embryos were available
on day 3; in this case, the blastocyst morphological se-
lection on day 5 was performed as previously described
[15] and the transferred embryo was chosen taking into
account both the IMCS score and the blastocyst mor-
phological score.
When the Eeva™ system was added to standard
morphology to assess embryo competence, embryos
were cultured in microwells of the Eeva™ dish (12 wells/
dish; one embryo/well), whose format allows following
each embryo individually even if all embryos share a
common 100 μL drop of medium (group culture). Em-
bryos were cultured in pre-equilibrated Cleavage
medium (Cook, Ireland) overlaid with mineral oil. Eeva™
microscopes were housed in tri-gas box incubators
(Panasonic) containing an atmosphere of 5% O2 and 6–
7% CO2, balanced with N2. A medium refresh step on
day 3 was performed using a new culture dish with pre-
equilibrated Blastocyst medium (Cook, Ireland) where
embryos were placed. Actually Eeva™ culture dishes have
12 microwells under a single drop of medium: each well
is identified by a letter (A, B, C, D) and a number (1, 2,
3): on day 3, embryos were moved from one dish to the
other keeping the same microwell order (A1 to A1 in
the new dish, etc.): This allowed to track individual em-
bryo development and accurately correlate Eeva™ score
on day 3 with embryo assessment on day 5. Dark field
images were acquired every 5 min from the time of cul-
ture start until ET, cryopreservation or discharge; a video
frame corresponded to 5 min in culture. All embryos
were likewise assessed by bright field microscopy on day
3 to manually insert blastomere number, allowing calcu-
lating Eeva™ score prior to ET. Eeva™ algorhythm gener-
ated a calculation of High or Low probability of
blastocyst formation based on kinetic growth parame-
ters: the P2 value (time between first and second mitosis;
P2 “high” range: 9.33–11.47 h) and the P3 value (time
between second and third mitosis; P3 “high” range:
0.00–1.73 h). After morphology plus Eeva™-based em-
bryo selection, either two embryos with “high” probabil-
ity of blastocyst formation (DET) or one blastocyst on
day 5 (SET) were transferred. In case of day 5 ET, the
transferred embryo was chosen taking into account both
the Eeva™ indication and the blastocyst morphological
score; in detail, Eeva™ rating was used to chose between
blastocysts with a similar morphological score.
The patients included in the study belonged to four
groups: (a) those receiving day 3 DET with embryos se-
lected by IMCS (DET-3M group, n = 106, receiving 212
embryos), (b) those receiving day 3 DET with embryos
selected by morphology plus Eeva™ (DET-3ME group,
n = 48, receiving 96 embryos), (c) those receiving day 5
SET with a blastocyst selected by conventional morph-
ology (IMCS and blastocyst score) (SET-5M group, n =
126, receiving 126 embryos), and (d) those receiving day
5 SET with a blastocyst selected by morphology plus
Eeva™ (SET-5ME group, n = 48, receiving 48 embryos).
Statistical analysis
Comparison among groups was performed using SAS
(SAS Institute, Cary, NC) software package, using the
unpaired t-test for continuous variables (shown as
mean ± SD) and the Fisher exact test for categorical vari-
ables (shown as percentage). All statistical tests were
two-sided and a P value of 0.05 or less was considered
statistically significant.
Results
Among a total number of 1178 couples that completed
IVF cycle in the study time period, 356 matched the inclu-
sion criteria, and 328 of them authorized the inclusion of
their data in the analysis. The clinical characteristics of the
enrolled patients and the outcome of their IVF cycles are
summarized in Tables 1 and 2, respectively.
All ETs were performed by experienced operators (AR,
AC, GG, LDP) using the soft catheter Sydney Guardia
(Cook, Australia) under transvaginal ultrasound guidance,
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applying the method that was previously published by our
group [13]. No ET resulted to be difficult or forced to
change catheter and to repeat the procedure.
Both subgroups of patients who received SET on day 5
had significantly more retrieved oocytes and higher ovar-
ian responsiveness to COS (ratio between total FSH dose
and retrieved oocytes, OSI) than the two subgroups that
had DET on day 3 (Table 1). This is due to the fact that
blastocyst transfer was performed only in patients with
at least four good scored embryos on day 3, whereas all
others patients received DET on day 3.
Overall, 1818 embryos were obtained in 328 IVF cy-
cles; 482 embryos were transferred in uteri, and 193 im-
planted (overall implantation rate: 40%) originating 161
US-verified clinical pregnancies (overall clinical preg-
nancy rate: 49.1%). Thirty-two pregnancies were twin
pregnancies, leading to an overall twinning rate of
19.8%, which is close to the average IVF twinning rate in
Italy; however, single blastocyst transfer on day 5 never
originated a twin pregnancy, whereas DET on day 3 ob-
tained a very high twinning rate (33.3% in the DET-3M
group, 59.2% in the DET-3ME group) (Table 2).
The clinical pregnancy rate was comparable in the
four subgroups, with slight differences (Table 2). The
implantation rate observed in DET-3ME group was sig-
nificantly higher than the one of DET-3M group (44.8%
vs. 30.2%, p < 0.02), whereas it was comparable to those
of groups SET-5M and SET-5ME (Table 2). Eighteen
Table 1 Clinical data of enrolled patients according to the embryo selection method
All DET-3 M DET-3 ME SET-5 M SET-5 ME p
(n = 328) (n = 106) (n = 48) (n = 126) (n = 48)
Age (years) 34.6 ± 3.0 34.7 ± 3.4 34.8 ± 3.0 34.2 ± 2.9 34.9 ± 1.9 ns
BMI (kg/m2) 23.6 ± 3.9 23.1 ± 3.6 23.2 ± 4.2 24.1 ± 4.2 24.6 ± 3.5 ns
Day 3 FSH (IU/I) 6.9 ± 1.5 7.1 ± 1.7 6.7 ± 1.3 6.7 ± 1.3 6.9 ± 1.8 ns
AMH (ng/ml) 3.7 ± 2.5 3.3 ± 1.9 3.0 ± 1.8 4.6 ± 3.2 3.6 ± 2.0 ns
AFC 15.4 ± 7.3 14.3 ± 6.0 15.4 ± 9.4 16.9 ± 8.2 15.2 ± 5.5 ns
Total exogenous FSH (IU) 2083.7 ± 823.7 2245.2 ± 940.7 2112.0 ± 841.0 1902.2 ± 671.2 2026.2 ± 736.7 ns
Peak E2 (pg/ml) 2437.2 ± 1097.9 1933.9 ± 867 1672.9 ± 1178.3 2211.3 ± 1171.1 2436.3 ± 1317.3 ns
OSI 6.6 ± 3.8 5.3 ± 3.0 5.5 ± 3.6 7.9 ± 3.6 8.3 ± 5.2 < 0.05*
Endometrial thickness (mm) 10.4 ± 2.0 10.2 ± 1.8 10.0 ± 2.2 10.7 ± 2.2 10.6 ± 1.7 ns
Retrieved oocytes 11.6 ± 4.0 10.2 ± 3.0 9.5 ± 2.6 13.4 ± 4.2 13.8 ± 4.9 < 0.05*
Mature (MII) oocytes (%) 83.5 ± 15.2 85.6 ± 12.6 78.1 ± 19.5 81.8 ± 15.6 89.1 ± 12.6 ns
Insemination technique (%) ns
IVF 24 (40/164) 26 (14/53) 25 (6/24) 25 (16/63) 17 (4/24)
ICSI 76 (124/164) 74 (39/53) 75 (18/24) 75 (47/63) 83 (20/24)
Fertilized (2PN) oocytes (%) 74.4 ± 17.6 69.8 ± 18.6 72.8 ± 18.3 79.7 ± 15.2 76.7 ± 16.6 ns
Cleaved embryos (%) 97.3 ± 7.9 96.8 ± 7.7 96.3 ± 11.6 98.0 ± 6.3 98.2 ± 7.1 ns
DET-3 M = patients receiving two day 3 embryos selected by IMCS; DET-3 ME = patients receiving two day 3 embryos selected by standard morphology plus Eeva™
score; SET-5 M = patients receiving one day 5 blastocyst selected by IMCS plus blastocyst morphological score; SET-5 ME = patients receiving one day 5 blastocyst
selected by blastocyst morphological score plus Eeva™. AFC = antral follicle count. OSI = ovarian sensitivity index (retrieved oocytes × 1000 / total FSH dose). Data
are expressed as mean ± SD or as absolute value and percentage. * Significance is referred to the comparison of both SET subgroups (SET-5 M and SET-5 ME) vs.
both DET subgroups (DET-3 M and DET-3 ME)
Table 2 Clinical outcome of IVF according to the embryo selection method
All (n = 328) Day 3 M Day 3E Day 5MM Day 5 EM p
(n = 106) (n = 48) (n = 126) (n = 48)
Transferred embryos 482 212 96 126 48
Clinical pregnancy rate (%) 49.1 (161/328) 45.3 (48/106) 56.2 (27/48) 49.2 (62/126) 50.0 (24/48) ns
Implantation rate (%) 40.0 (193/482) 30.2 (64/212) 44.8 (43/96) 49.2 (62/126) 50.0 (24/48) < 0.02*
Twin pregnancy rate (%) 19.8 (32/161) 33.3 (16/48) 59.2 (16/27) 0/62 0/24
Ongoing pregnancy rate (%) 43.6 (143/328) 39.6 (42/106) 50.0 (24/48) 43.6 (55/126) 45.8 (22/48) ns
DET-3 M = patients receiving two day 3 embryos selected by IMCS; DET-3 ME = patients receiving two day 3 embryos selected by standard morphology plus Eeva™
score; SET-5 M = patients receiving one day 5 blastocyst selected by IMCS plus blastocyst morphological score; SET-5 ME = patients receiving one day 5 blastocyst
selected by blastocyst morphological score plus Eeva™. Data are expressed as absolute value and percentage. * Significance is referred to the comparison of DET-
3 M vs. DET-3 ME, SET-5 M and SET-5 ME
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pregnancies underwent a spontaneous miscarriage in the
first trimester, and finally the ongoing pregnancy rate at
12 weeks gestational age was similar in the four sub-
groups, without any significant difference (Table 2).
Discussion
The selection of embryos having the highest competence
for pregnancy and live birth has been based for years on a
single observation by inverted light microscopy performed
on day 2, 3 or 5 of embryo culture. Repeated observations,
although likely to give better insights about embryo com-
petence, were used with caution because even a short ex-
posure of embryos to suboptimal conditions outside the
controlled environment of the incubator was thought to
potentially affect the implantation potential.
The introduction of time-lapse technology (TLT) into
the clinical practice has allowed providing a continuous
surveillance of embryo growth, while maintaining stable
culture conditions; moreover, the recording of previously
unknown kinetic parameters of embryo development
has provided new embryo-related variables available for
analysis [8]. TLT was claimed to have the potential to
improve embryo selection capability and, as a conse-
quence, IVF outcome; indeed some studies reported
higher pregnancy rates using TLT (reviewed in [12]), but
others could not confirm this finding as they failed to
observe any improvement of IVF results vs. the standard
morphological embryo selection [5, 9, 10].
So far, none of the studies comparing TLT to the sin-
gle observation, morphological embryo assessment used
the evidence-based score named IMCS as a reference
[6]. The difference between IMCS and the other scoring
methods is that IMCS was constructed comparing the
morphology of surely implanted embryos (dizygotic twin
pregnancies after DET) vs. surely non-implanted em-
bryos (no pregnancy after DET), and was therefore
based on the evidence of implantation and clinical preg-
nancy. Indeed IMCS is the morphological score that was
incorporated into a complex prediction model for IVF
outcome, recently shown to predict live birth with a re-
markably good precision [14]. Actually the present study
is the first comparing embryo selection performed by an
evidence-based morphological score vs. TLT.
In our study we aimed at assessing the impact of the
adjunctive use of the Early Embryo Viability Assessment
(Eeva™), an algorhythm for automatic embryo scoring at
the cleavage stage, on the embryo selection process per-
formed using conventional morphology. The possibility to
predict the development of embryos observed in the first
days of growth to the blastocyst stage, a concept underlying
Eeva™ test, was previously demonstrated [3, 11, 17], and
Eeva™ was found to be more reliable than a panel of embry-
ologists with diverse experience in assessing embryo poten-
tial to evolve to blastocyst [4]. The clinical application of
Eeva™ was already tested in a few studies, but conflicting
results were obtained: an improved possibility of identifi-
cation of cleaving embryos prone to reach the blastocyst
stage was shown in a multicenter study [2], a positive ef-
fect of Eeva™ application on implantation and pregnancy
rates was reported in other studies [1, 16], but some au-
thors failed to observe any significant difference in preg-
nancy rates when Eeva™ was used in association with
standard morphology vs. morphology alone performed on
day 3 [9] or day 5 [7, 18].
We performed the present analysis on a very homoge-
neous patients’ population, that was selected using very
strict inclusion criteria; this strategy allowed obtaining
four groups of patients with very similar clinical charac-
teristics. The potentially confounding variable of the day
chosen for ET (day 3 vs. day 5) was accounted for in-
cluding in the study a subgroup in which Eeva™ was per-
formed on day 3, but a single embryo was transferred on
day 5, after a selection process that considered together
Eeva™ results and blastocyst morphology.
Overall, we observed that when two embryos were se-
lected using morphology plus Eeva™ and transferred on
day 3 (DET-3ME group), the implantation rate was sig-
nificantly higher than when the IMCS alone was used
(DET-3M group); interestingly enough, the implantation
rate of Eeva™-selected embryos on day 3 was comparable
to the one of blastocysts morphologically selected and
transferred on day 5 (SET-5M and SET-5ME groups).
On one side this led to an unacceptably high twinning
rate in the DET-3ME group - suggesting that when
Eeva™ is used to select embryos, only one embryo should
be transferred in uteri – on the other side it demon-
strated that Eeva™ has a remarkable efficacy in identify-
ing which day 3 embryos have the best chance of
development to blastocyst and implantation.
The positive effect of Eeva™ addition to classical
morphology on the accuracy of embryo selection, how-
ever, was lost when embryo culture was prolonged to
day 5; in fact, comparable implantation rates were ob-
tained after single blastocyst transfer regardless Eeva™
was considered or not to chose the embryo to transfer.
To this purpose it should be remarked that Eeva™ was
constructed for use on day 3, and probably considering
its results for the blastocyst selection process on day 5
represents an improper use.
Despite the described differences in the implantation
rate, in our study both the clinical pregnancy rate and
the ongoing pregnancy rate at 12 weeks were not signifi-
cantly different in the four groups. This may be likely
due to the relative low number of observations in some
groups, but it may be noticed that even other authors re-
ported that Eeva™ was ineffective in increasing the on-
going pregnancy rate when compared to a standard
morphological score [7, 9]. Also a study showing an
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increased pregnancy rate with Eeva™, unfortunately did
not report about the ongoing pregnancy rate [1].
A limitation of our study, besides its retrospective na-
ture, was that embryos were cultured in different incu-
bators (Eeva™ vs. low oxygen tension incubators), culture
dishes and volumes, and the influence of the culture
conditions could not be clearly distinguished from the
effect of embryo selection strategy. This confounder
could not be eliminated because Eeva™ system cannot be
housed in any incubator, but requires a specific model.
We are aware that our results may not be considered
conclusive and should be verified on a larger scale and/
or in properly weighted prospective trials. However, with
all the above limitations, our findings suggest that Eeva™
algorhythm could be useful in improving the embryo se-
lection accuracy of standard morphology when ET on
day 3 is scheduled. Further, Eeva™ could be quite useful
when applied to perform a SET on day 3, as according
to our findings it could obtain clinical results compar-
able to the more time-demanding SET on day 5, after
blastocyst culture.
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